| |
| |
|
| Insider
Information: |
Manning Anthony M. |
| Relationship: |
Chief Scientific Officer |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
36,693 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$68,616 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,693 |
|
|
| Total
Value |
$68,616 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Palatin Technologies Inc |
PTN |
|
2023-06-20 |
36,693 |
2017-09-07 |
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Chief Scientific Officer |
2020-10-01 |
0 |
2018-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,778) |
0 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-02-18 |
4 |
AS |
$32.56 |
$535,905 |
D/D |
(16,459) |
5,068 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-11-13 |
4 |
AS |
$16.52 |
$10,231 |
D/D |
(619) |
5,443 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-12-24 |
4 |
AS |
$20.00 |
$1,028,900 |
D/D |
(51,445) |
5,443 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-01-15 |
4 |
AS |
$28.44 |
$828,002 |
D/D |
(29,114) |
5,443 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-01-22 |
4 |
AS |
$29.01 |
$65,710 |
D/D |
(2,265) |
5,443 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-11-07 |
4 |
AS |
$15.96 |
$134,383 |
D/D |
(8,420) |
5,818 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-02-11 |
4 |
AS |
$32.23 |
$3,610 |
D/D |
(112) |
5,857 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-02-10 |
4 |
AS |
$31.50 |
$7,056 |
D/D |
(224) |
5,969 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-11-12 |
4 |
AS |
$16.18 |
$2,734 |
D/D |
(169) |
6,062 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
6,193 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-11-08 |
4 |
AS |
$16.06 |
$5,412 |
D/D |
(337) |
6,231 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-11-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
6,568 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-10-14 |
4 |
AS |
$13.55 |
$10,664 |
D/D |
(787) |
6,603 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-06-20 |
4 |
AS |
$13.00 |
$512,629 |
D/D |
(39,433) |
6,980 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-12 |
4 |
AS |
$11.64 |
$1,327 |
D/D |
(114) |
7,390 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-08 |
4/A |
AS |
$11.67 |
$2,637 |
D/D |
(226) |
7,504 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-08 |
4 |
AS |
$11.82 |
$2,612 |
D/D |
(221) |
7,509 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-01-21 |
4 |
AS |
$30.08 |
$37,149 |
D/D |
(1,235) |
7,708 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2019-08-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
7,730 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
8,943 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-03-06 |
4 |
AS |
$29.00 |
$211,990 |
D/D |
(7,310) |
12,758 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-04-21 |
4 |
AS |
$30.55 |
$57,617 |
D/D |
(1,886) |
12,758 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-05-11 |
4 |
AS |
$33.75 |
$13,973 |
D/D |
(414) |
12,758 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2020-07-21 |
4 |
AS |
$34.67 |
$67,260 |
D/D |
(1,939) |
12,778 |
0 |
% |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
